| Size & multiples | |||
| Market Cap | $5.79B | Enterprise Value | $10.50B |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 1.09× | P/FCF | 42.23× |
| EV/EBITDA | 14.30× | EV/EBIT | 32.50× |
| EV/Sales | 1.97× | EV/FCF | 76.61× |
| FCF Yield | 2.37% | Buyback Yield | — |
| Owner Earnings (TTM) | -$81.0M | Owner Earnings Yield | −1.40% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.54 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 6.70% |
| After-tax Cost of Debt | — | Synthetic credit rating | CCC |
| Cost of Debt · embedded (pre-tax) | 7.66% | Cost of Debt · marginal (synthetic) | 12.85% |
| WACC | — | ROIC | 0.80% |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$1.02 · revenue TTM $5.32B · FCF TTM $137.0M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on EV/EBITDA
EV/EBITDA 67th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| EV/EBITDA | 19.6x | 15.2x | 9.9x–24.7x | 67 ↑rich |
| FCF Yield | -1.1% | -7.9% | -35.6%–1.4% | 66 ↑strong |
| Net Margin | -7.1% | -21.2% | -325.3%–7.2% | 58 ↑strong |
| Operating Margin | 2.2% | -34.5% | -552.0%–8.0% | 68 ↑strong |
| ROE | -5.6% | -36.8% | -92.5%–4.5% | 69 ↑strong |
